Close Menu

NEW YORK (360Dx) – Time savings offered by new antimicrobial test systems may not persuade laboratory directors to invest in new instruments and kits.

As newer and faster technologies for rapid antimicrobial resistance and susceptibility testing begin to make their way to market, older methods still have throughput and price advantages over them, some lab managers said.

Get the full story with
360Dx Premium

Only $95 for the
first 90 days*

360Dx Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try 360Dx Premium now.

You may already have institutional access!

Check if I qualify.

Already a 360Dx or GenomeWeb Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.